Move for Surgery (MFS): Evaluating the Use of Wearable Technology for Preconditioning Before Thoracic Surgery

NCT03902834 | Completed

• 1 other identifier: BFCRS-333417
• Study Type: interventional
• Target: 25
• Locations: 1 country
• Sites: 1

Brief Summary

Wearable technology is increasingly being used to promote healthy behaviour. In this study, the investigators propose the development and evaluation of Move for Surgery, which utilizes a wearable activity bracelet (Fitbit) and proven behavioural change techniques, for preconditioning of patients prior to lung cancer surgery. The primary outcome of this study will be compliance with Move for Surgery, as a surrogate measure for feasibility. Secondary outcomes, including accrual rates, perioperative pulmonary complications, cost per patient, and patient satisfaction, will also be collected. The investigators have partnered with the Canadian Partnership Against Cancer (CPAC) and Lung Cancer Canada (LCC) to develop Move for Surgery. The ultimate goal of this preliminary study is to lay the groundwork for a subsequent comparative trial to evaluate the impact of Move for Surgery on postoperative complications in the thoracic surgery population.

Conditions

Preconditioning; Lung Cancer, Nonsmall Cell

Outcome Measures

Primary Outcomes (1)

• The feasibility of Move for Surgery, as measured by a rate of compliance of >70% until program completion.

  The feasibility of Move for Surgery, as measured by a rate of compliance of \>70% until program completion.

  12 months

Secondary Outcomes (5)

• Rate of accrual

  12 months

• Perioperative patient complications

  12 months

• Cost per patient

  12 months

• Patient-reported health-related quality of life

  12 months

• Patient-reported health-related physical activity

  12 months

Study Arms (1)

Intervention

EXPERIMENTAL

Other: Fitbit

Interventions

Fitbit OTHER

Use the wearable technology (Fitbit) and proven behavioural change techniques to precondition patients prior to lung cancer surgery

Also known as: Wearable Technology

Intervention

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Eligible participants include patients with NSCLC set to undergo pulmonary resection.

Sponsors & Collaborators

• St. Joseph's Healthcare Hamilton: lead

Study Sites (1)

St. Joseph's Healthcare Hamilton

Hamilton, Ontario, L8N 4A6, Canada

Location

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

Wearable Electronic Devices

Condition Hierarchy (Ancestors)

Carcinoma, Bronchogenic; Bronchial Neoplasms; Lung Neoplasms; Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Electrical Equipment and Supplies; Equipment and Supplies

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor of Surgery

Study Record Dates

• First Submitted: January 30, 2018
• First Posted: April 4, 2019
• Study Start: November 30, 2017
• Primary Completion: September 12, 2018
• Study Completion: September 12, 2018
• Last Updated: April 8, 2019

Record last verified: 2019-04

Data Sharing

• IPD Sharing: Will not share

Locations

CA (1)